GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (WBO:ILMN) » Definitions » Valuation Rank

Illumina (WBO:ILMN) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Illumina Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Illumina Valuation Rank Related Terms

Thank you for viewing the detailed overview of Illumina's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (WBO:ILMN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (WBO:ILMN) » Definitions » Valuation Rank
Comparable Companies
WAT LH DGX ICLR RVTY MTD MEDP CRL NTRA EXAS TMO DHR IQV XSWX:LONN IDXX A SHSE:603259 XPAR:BIM XPAR:ERF QGEN
Traded in Other Exchanges
ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Website
https://www.illumina.com
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.